Kanda Y - Search Results

1

Echinochrome Prevents Sulfide Catabolism-Associated Chronic Heart Failure after Myocardial Infarction in Mice.

Tang X, Nishimura A, Ariyoshi K, Nishiyama K, Kato Y, Vasileva EA, Mishchenko NP, Fedoreyev SA, Stonik VA, Kim HK, Han J, Kanda Y, Umezawa K, Urano Y, Akaike T, Nishida M. Tang X, et al. Among authors: kanda y. Mar Drugs. 2023 Jan 12;21(1):52. doi: 10.3390/md21010052. Mar Drugs. 2023. PMID: 36662225 Free PMC article.

2

Depolysulfidation of Drp1 induced by low-dose methylmercury exposure increases cardiac vulnerability to hemodynamic overload.

Nishimura A, Shimoda K, Tanaka T, Toyama T, Nishiyama K, Shinkai Y, Numaga-Tomita T, Yamazaki D, Kanda Y, Akaike T, Kumagai Y, Nishida M. Nishimura A, et al. Among authors: kanda y. Sci Signal. 2019 Jun 25;12(587):eaaw1920. doi: 10.1126/scisignal.aaw1920. Sci Signal. 2019. PMID: 31239323

3

Lysophosphatidic Acid Promotes the Expansion of Cancer Stem Cells via TRPC3 Channels in Triple-Negative Breast Cancer.

Hirata N, Yamada S, Yanagida S, Ono A, Yasuhiko Y, Nishida M, Kanda Y. Hirata N, et al. Among authors: kanda y. Int J Mol Sci. 2022 Feb 10;23(4):1967. doi: 10.3390/ijms23041967. Int J Mol Sci. 2022. PMID: 35216080 Free PMC article.

4

[Preface].

Nishida M, Kanda Y. Nishida M, et al. Among authors: kanda y. Nihon Yakurigaku Zasshi. 2022;157(2):110. doi: 10.1254/fpj.21109. Nihon Yakurigaku Zasshi. 2022. PMID: 35228440 Japanese. No abstract available.

5

Drug repurposing for the treatment of COVID-19.

Kato Y, Nishiyama K, Nishimura A, Noda T, Okabe K, Kusakabe T, Kanda Y, Nishida M. Kato Y, et al. Among authors: kanda y. J Pharmacol Sci. 2022 Jul;149(3):108-114. doi: 10.1016/j.jphs.2022.04.007. Epub 2022 Apr 25. J Pharmacol Sci. 2022. PMID: 35641023 Free PMC article. Review.

6

SARS-CoV-2 induces barrier damage and inflammatory responses in the human iPSC-derived intestinal epithelium.

Yamada S, Noda T, Okabe K, Yanagida S, Nishida M, Kanda Y. Yamada S, et al. Among authors: kanda y. J Pharmacol Sci. 2022 Jul;149(3):139-146. doi: 10.1016/j.jphs.2022.04.010. Epub 2022 May 2. J Pharmacol Sci. 2022. PMID: 35641026 Free PMC article. Review.

7

TRPC3-Nox2 Protein Complex Formation Increases the Risk of SARS-CoV-2 Spike Protein-Induced Cardiomyocyte Dysfunction through ACE2 Upregulation.

Kato Y, Nishiyama K, Man Lee J, Ibuki Y, Imai Y, Noda T, Kamiya N, Kusakabe T, Kanda Y, Nishida M. Kato Y, et al. Among authors: kanda y. Int J Mol Sci. 2022 Dec 21;24(1):102. doi: 10.3390/ijms24010102. Int J Mol Sci. 2022. PMID: 36613540 Free PMC article.

8

Activation of the urotensin-II receptor by remdesivir induces cardiomyocyte dysfunction.

Ogawa A, Ohira S, Kato Y, Ikuta T, Yanagida S, Mi X, Ishii Y, Kanda Y, Nishida M, Inoue A, Wei FY. Ogawa A, et al. Among authors: kanda y. Commun Biol. 2023 May 12;6(1):511. doi: 10.1038/s42003-023-04888-x. Commun Biol. 2023. PMID: 37173432 Free PMC article.

9

Supersulfide prevents cigarette smoke extract-induced mitochondria hyperfission and cardiomyocyte early senescence by inhibiting Drp1-filamin complex formation.

Nishimura A, Zhou L, Kato Y, Mi X, Ito T, Ibuki Y, Kanda Y, Nishida M. Nishimura A, et al. Among authors: kanda y. J Pharmacol Sci. 2024 Feb;154(2):127-135. doi: 10.1016/j.jphs.2023.12.008. Epub 2023 Dec 27. J Pharmacol Sci. 2024. PMID: 38246726 Free article.

10

SARS-CoV-2 causes dysfunction in human iPSC-derived brain microvascular endothelial cells potentially by modulating the Wnt signaling pathway.

Yamada S, Hashita T, Yanagida S, Sato H, Yasuhiko Y, Okabe K, Noda T, Nishida M, Matsunaga T, Kanda Y. Yamada S, et al. Among authors: kanda y. Fluids Barriers CNS. 2024 Apr 8;21(1):32. doi: 10.1186/s12987-024-00533-9. Fluids Barriers CNS. 2024. PMID: 38584257 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,358 results

Search Page